Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
AstraZeneca
AstraZeneca
National Taiwan University Hospital
University of Southern California
Merck Sharp & Dohme LLC
Zhejiang Cancer Hospital
National Cancer Institute (NCI)
Novo Nordisk A/S
Eastern Cooperative Oncology Group
New Mexico Cancer Research Alliance
Chinese University of Hong Kong
Sun Yat-sen University
University of Miami
Seoul National University Hospital
University of Pittsburgh
Otsuka Pharmaceutical Co., Ltd.
City of Hope Medical Center
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Nihon University
Stanford University
NYU Langone Health
Kindai University
Shanghai Jiao Tong University School of Medicine